MedTrace Logo

Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

NCT01494896 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2015-05-07

No results posted yet for this study

Summary

The purpose of this study is to see how inhaled treprostinil sodium (Tyvaso) affects the amount of air and blood that reach the alveoli, or tiy air sacs, in the lungs of patients with Group 1 Pulmonary Arterial Hypertension with concomitant Chronic Obstructive Pulmonary Disease (COPD).

Conditions

Sponsors & Collaborators

  • United Therapeutics

    collaborator INDUSTRY

  • University of Florida

    lead OTHER

Principal Investigators

  • Abubakr A Bajwa, MD, FCCP · University of Florida

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01494896 on ClinicalTrials.gov